Bleomycin-induced Sweet's syndrome
- PMID: 40844068
- PMCID: PMC12419575
- DOI: 10.4103/ijp.ijp_134_25
Bleomycin-induced Sweet's syndrome
Abstract
Sweet's syndrome is also called as acute febrile neutrophilic dermatosis. Drug-induced Sweet's syndrome was first reported in association with trimethoprim-sulfamethoxazole. It is very rare. To the best of our knowledge, bleomycin-induced Sweet's syndrome has not been reported previously.
Keywords: Bleomycin; Sweet’ syndrome; chemotherapy.
Copyright © 2025 Indian Journal of Pharmacology.
Conflict of interest statement
There are no conflicts of interest.
Figures


References
-
- Yamamoto T. Bleomycin and the skin. Br J Dermatol. 2006;155:869–75. - PubMed
-
- Cohen IS, Mosher MB, O’Keefe EJ, Klaus SN, De Conti RC. Cutaneous toxicity of bleomycin therapy. Arch Dermatol. 1973;107:553–5. - PubMed
-
- Walker DC, Cohen PR. Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: Case report and review of drug-induced Sweet’s syndrome. J Am Acad Dermatol. 1996;34:918–23. - PubMed
-
- Cohen PR, Kurzrock R. Sweet’s syndrome and cancer. Clin Dermatol. 1993;11:149–57. - PubMed
-
- Cohen PR, Kurzrock R. Treatment of Sweet’s syndrome. Am J Med. 1990;89:396. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources